Log in to save to my catalogue

SMN Protein Can Be Reliably Measured in Whole Blood with an Electrochemiluminescence (ECL) Immunoass...

SMN Protein Can Be Reliably Measured in Whole Blood with an Electrochemiluminescence (ECL) Immunoass...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1771446356

SMN Protein Can Be Reliably Measured in Whole Blood with an Electrochemiluminescence (ECL) Immunoassay: Implications for Clinical Trials

About this item

Full title

SMN Protein Can Be Reliably Measured in Whole Blood with an Electrochemiluminescence (ECL) Immunoassay: Implications for Clinical Trials

Publisher

United States: Public Library of Science

Journal title

PloS one, 2016-03, Vol.11 (3), p.e0150640-e0150640

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Spinal muscular atrophy (SMA) is caused by defects in the survival motor neuron 1 (SMN1) gene that encodes survival motor neuron (SMN) protein. The majority of therapeutic approaches currently in clinical development for SMA aim to increase SMN protein expression and there is a need for sensitive methods able to quantify increases in SMN protein le...

Alternative Titles

Full title

SMN Protein Can Be Reliably Measured in Whole Blood with an Electrochemiluminescence (ECL) Immunoassay: Implications for Clinical Trials

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1771446356

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1771446356

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0150640

How to access this item